| Primary |
| Hypoglycaemia |
9.4% |
| Constipation |
8.3% |
| Gastritis |
8.3% |
| Gastrointestinal Endoscopic Therapy |
8.3% |
| Product Used For Unknown Indication |
7.3% |
| Nausea |
6.3% |
| Glucagon Tolerance Test |
5.2% |
| Blood Glucose Decreased |
4.2% |
| Colonoscopy |
4.2% |
| Diabetes Mellitus |
4.2% |
| Drug Use For Unknown Indication |
4.2% |
| Endoscopy Upper Gastrointestinal Tract |
4.2% |
| Type 1 Diabetes Mellitus |
4.2% |
| Anaemia |
3.1% |
| Endoscopic Retrograde Cholangiopancreatography |
3.1% |
| Endoscopy |
3.1% |
| Endoscopy Gastrointestinal |
3.1% |
| Hyperlipidaemia |
3.1% |
| Hypertension |
3.1% |
| Neurogenic Bladder |
3.1% |
|
| Loss Of Consciousness |
20.8% |
| Pharmaceutical Product Complaint |
12.5% |
| Lactic Acidosis |
6.3% |
| Rhabdomyolysis |
6.3% |
| Syncope |
6.3% |
| Dizziness |
4.2% |
| Drug Dose Omission |
4.2% |
| Drug Ineffective |
4.2% |
| Feeling Abnormal |
4.2% |
| Hypopnoea |
4.2% |
| Hypotension |
4.2% |
| Medication Error |
4.2% |
| Shock |
4.2% |
| Abortion Spontaneous |
2.1% |
| Anaphylactic Reaction |
2.1% |
| Blood Glucose Abnormal |
2.1% |
| Blood Glucose Decreased |
2.1% |
| Blood Glucose Increased |
2.1% |
| Death |
2.1% |
| Dyspnoea |
2.1% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
22.0% |
| Type 1 Diabetes Mellitus |
11.6% |
| Diabetes Mellitus |
11.0% |
| Hypoglycaemia |
8.1% |
| Hypotension |
5.8% |
| Blood Glucose Decreased |
4.6% |
| Hypertension |
4.6% |
| Resuscitation |
4.6% |
| Cardiac Disorder |
4.0% |
| Product Used For Unknown Indication |
3.5% |
| Cardiogenic Shock |
2.9% |
| Convulsion |
2.9% |
| Neuropathy Peripheral |
2.9% |
| Depression |
2.3% |
| Intestinal Polypectomy |
2.3% |
| Diagnostic Procedure |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Hyperglycaemia |
1.2% |
| Oesophageal Food Impaction |
1.2% |
| Tremor |
1.2% |
|
| Wrong Technique In Drug Usage Process |
13.9% |
| Vomiting |
8.3% |
| Drug Interaction |
5.6% |
| Dyspnoea |
5.6% |
| Lipohypertrophy |
5.6% |
| Pain In Extremity |
5.6% |
| Somnolence |
5.6% |
| Therapeutic Response Delayed |
5.6% |
| Therapeutic Response Prolonged |
5.6% |
| Tremor |
5.6% |
| Visual Acuity Reduced |
5.6% |
| Wrong Drug Administered |
5.6% |
| Blood Glucose Increased |
2.8% |
| Cellulitis |
2.8% |
| Convulsion |
2.8% |
| Death |
2.8% |
| Diabetic Coma |
2.8% |
| Drug Dose Omission |
2.8% |
| Hyperkalaemia |
2.8% |
| Hypoglycaemia |
2.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
64.0% |
| Drug Use For Unknown Indication |
21.3% |
| Pain |
1.8% |
| Hypertension |
1.5% |
| Diabetes Mellitus |
1.4% |
| Hypoglycaemia |
1.1% |
| Multiple Myeloma |
1.0% |
| Depression |
0.8% |
| Diagnostic Procedure |
0.8% |
| Type 2 Diabetes Mellitus |
0.7% |
| Gastritis Atrophic |
0.7% |
| Constipation |
0.7% |
| Cardiac Operation |
0.6% |
| Nausea |
0.6% |
| Neoplasm Malignant |
0.6% |
| Diarrhoea |
0.5% |
| Angle Closure Glaucoma |
0.5% |
| Blood Pressure |
0.5% |
| Anxiety |
0.4% |
| Hepatitis C |
0.4% |
|
| Vomiting |
12.4% |
| Thrombocytopenia |
8.5% |
| Weight Decreased |
7.8% |
| Hypoglycaemia |
5.4% |
| Pneumonia |
5.4% |
| Pyrexia |
5.4% |
| Sepsis |
5.4% |
| Urinary Tract Infection |
5.4% |
| Renal Failure |
4.7% |
| Shock |
4.7% |
| Transfusion |
4.7% |
| Ventricular Tachycardia |
4.7% |
| Vision Blurred |
4.7% |
| Diverticulitis |
3.9% |
| Thrombosis |
3.9% |
| Pneumothorax |
3.1% |
| Tricuspid Valve Incompetence |
3.1% |
| Arthralgia |
2.3% |
| Blood Glucose Increased |
2.3% |
| Confusional State |
2.3% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
100.0% |
|
|
